消息面上，据港交所11月20日披露，蔓迪国际递表港交所主板。招股书显示，蔓迪国际是中国领先的专 业消费医药公司，致力于开发并提供全面和长期的皮肤健康及体重管理解决方案。公司主要专注于更广 泛的皮肤健康行业中的头发健康领域，并在此领域确立了领导地位。 三生制药发布公告称，公司拟拆分子公司蔓迪国际于港交所独立上市。同时三生制药在公告中称，分拆 完成后，公司将不会保留蔓迪国际的任何权益，蔓迪国际将不再是三生制药的附属公司，蔓迪国际将独 立运营。 智通财经APP获悉，三生制药(01530)早盘涨超7%，截至发稿，涨5.25%，报30.88港元，成交额4.01亿港 元。 ...

三生制药(01530)早盘涨超7%，截至发稿，涨5.25%，报30.88港元，成交额4.01亿港元。 三生制药发布公告称，公司拟拆分子公司蔓迪国际于港交所独立上市。同时三生制药在公告中称，分拆 完成后，公司将不会保留蔓迪国际的任何权益，蔓迪国际将不再是三生制药的附属公司，蔓迪国际将独 立运营。 消息面上，据港交所11月20日披露，蔓迪国际递表港交所主板。招股书显示，蔓迪国际是中国领先的专 业消费医药公司，致力于开发并提供全面和长期的皮肤健康及体重管理解决方案。公司主要专注于更广 泛的皮肤健康行业中的头发健康领域，并在此领域确立了领导地位。 ...

Group 1: Recent IPOs - Zhongwei Co., a new energy materials company, officially listed on the Hong Kong Stock Exchange, raising approximately HKD 3.544 billion by offering about 104 million shares [1] - Jiansu, a supply chain management service provider, submitted an IPO application to the SEC for a Nasdaq listing, focusing on the plastic and chemical industries in China [2] - Defeng Technology, an independent AIoT provider, filed for an IPO on the Hong Kong Stock Exchange, specializing in energy and manufacturing sectors [3] - Kanop, an industrial robotics company, applied for an IPO on the Hong Kong Stock Exchange, ranking first among Chinese welding robot manufacturers [4] - NobiKan, an AI company, refiled for an IPO on the Hong Kong Stock Exchange after previous applications lapsed, focusing on AI and digital twin technologies [5] - Dongshan Precision, a PCB supplier for edge AI devices, submitted an IPO application to the Hong Kong Stock Exchange, aiming to become a leading supplier in the sector [6] - Mandi International, a consumer healthcare company, filed for an IPO on the Hong Kong Stock Exchange, leading the market in hair health products [7] - Lingyi Intelligent Manufacturing, an AI hardware platform, applied for an IPO on the Hong Kong Stock Exchange, ranking first in high-precision components for AI terminal devices [8] Group 2: Upcoming IPOs - Quantitative Platform is set to launch its IPO from November 19 to November 24, aiming to raise approximately HKD 131 million [9] - Haiwei Electronics plans to conduct its IPO from November 20 to November 25, targeting to raise around HKD 440 million [10] Group 3: Recent Hearings - Yujian Xiaomian, a modern Chinese noodle brand, passed the listing hearing on the Hong Kong Stock Exchange, operating 440 restaurants in mainland China and 11 in Hong Kong [11] - Jinyan High-tech, a kaolin company, also passed the listing hearing, focusing on the production of calcined kaolin products [12] - Naxin Micro, a provider of analog chips, passed the listing hearing, specializing in automotive electronics and consumer electronics [13] - Lemo, a smart massage service provider, passed the listing hearing, leading the market in smart massage services in mainland China [14] Group 4: Market Developments - The Singapore Exchange and Nasdaq announced a collaboration to simplify dual listings, aiming to launch a "Global Listing Board" by mid-2026 [15]

根据灼识咨询数据，按零售额计，其旗舰产品蔓迪系列米诺地尔类脱发治疗产品自2014年起，连续十年 在中国脱发药物市场及米诺地尔类药物市场排名第一。 2025年3月，蔓迪国际推出了蔓迪防脱发洗发水，这是中国首款添加乌诺地尔防脱发成分的功效型防脱 发洗发产品。该款洗发水上市首六个月销售量已超过50万瓶。 蔓迪国际向香港交易所主板递交上市申请。华泰国际是独家保荐人。 2024年，蔓迪系列产品在中国脱发药物市场及米诺地尔类药物市场的份额分别约为57%和71%。 公司定位为中国领先的专业消费医药公司，致力于开发并提供全面的皮肤健康及体重管理解决方案。蔓 迪国际在更广泛的皮肤健康行业中，尤其在头发健康领域确立了领导地位。 ...

智通财经APP获悉，据港交所11月20日披露，蔓迪国际递表港交所主板，华泰国际为其独家保荐人。招股书显示，蔓迪国际是 中国领先的专业消费医药公司，致力于开发并提供全面和长期的皮肤健康及体重管理解决方案。公司主要专注于更广泛的皮肤 健康行业中的头发健康领域，并在此领域确立了领导地位。 根据灼识咨询的资料，按零售额计，蔓迪国际的旗舰产品蔓迪®系列米诺地尔类脱发治疗产品自2014年起连续十年在中国脱发 药物市场及米诺地尔类药物市场排名第一，在上述两个市场于2024年的市场份额分别为约57%及71%。 于2025年3月，蔓迪国际推出蔓迪®防脱发洗发水，这是中国首款添加乌诺地尔防脱发成份的功效防脱发洗发产品。上市首六个 月即创下逾50万瓶销售量，重新定义了中国国内防脱发及护发市场格局。 | 偏纂]的[編纂]數目 : [編纂](視乎[編纂]行使與否而定) | .. | [編纂]數目 | 【繼纂】(可予 編纂】) | | --- | --- | --- | --- | | [編纂]數目 | ： [編纂](可予[編纂]及視乎[編纂]行使與 | 否而定) | | | 最高[編纂] : 每股[編纂]港元,另加1.0%經紀佣金、 ...

Core Viewpoint - The article discusses the marginal recovery of the US economy, highlighting improvements in GDP growth, employment stability, inflation pressures, and market expectations for interest rate cuts by the Federal Reserve [2][3]. Group 1: US Economic Recovery - The Atlanta Fed's GDPNOW model predicts a Q3 GDP growth rate of 2.5%, with private consumption growth at 2.0% and private investment growth at 2.5%, indicating a recovery from Q2's low [2]. - Initial jobless claims remain low at 226,000, while continuing claims are at 1.974 million, suggesting a stable employment market with limited upward pressure on the unemployment rate [2]. - Service consumption growth is forecasted at 1.9% for Q3, up from 1.4% in Q2, potentially reversing the trend of cooling service inflation [2]. Group 2: Interest Rate Expectations - Market sentiment is influenced by Trump's nomination of Stephen Moore to the Federal Reserve, with expectations for a 25 basis point rate cut in September and 2-3 cuts anticipated for the year [2][3]. - The bond market reflects these expectations, with US Treasury yields remaining low and limited further downside anticipated due to already priced-in rate cuts [3]. Group 3: Currency and Commodity Outlook - The US dollar is expected to remain stable, with limited downside as the market has largely priced in the September rate cut [5]. - Gold prices are influenced by potential tariffs on gold bars, leading to a significant price spread between New York and London gold [6]. Group 4: China's Economic Performance - China's exports grew by 7.2% year-on-year in July, with imports rising by 4.1%, indicating better-than-expected trade performance [8]. - Domestic real estate transactions are down 25.1% year-on-year, with second-hand home prices declining, reflecting ongoing pressure in the housing market [9]. Group 5: Policy Initiatives - The People's Bank of China and other departments issued guidelines to support new industrialization through financial services, focusing on innovation and supply chain resilience [10][11]. - The "anti-involution" policy aims to direct financial resources towards technological innovation and brand upgrades, while monitoring credit flows to prevent risks [11]. Group 6: Market Strategy - The market shows a steady recovery in risk appetite, with both stock and bond markets experiencing slight upward movements [12]. - A balanced allocation strategy is recommended for equities, focusing on dividend-paying sectors and technology, while maintaining a cautious approach to long-duration bonds [14].